1. National differences in patient-clinician communication regarding hypoactive sexual desire disorder;Goldstein;J Sex Med,2009
2. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis;Atlantis;J Sex Med,2012
3. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis;Jaspers;JAMA Intern Med,2016
4. FDA 2015: Clinical Background Document for the Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and Drug Safety and Risk Management (DSaRM) Advisory Committee, June 4, 2015, Flibanserin, Division of Bone, Reproductive and Urologic Products, Office of Drug Evaluation III, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, May 8, 2015.
5. FDA Advisory Committee For Reproductive Health Drugs: Intrinsa,2004